The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 7%. Our forward projection puts the odds of a 10% gain over the next month near 0%.
FTAI Aviation Ltd. FTAIN
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · FTAI Aviation Ltd.
read at $24.99
FTAI Aviation Ltd. holds its Accumulation at $24.99.
- PHPhase · the trend structure carries the Accumulation label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · does not pass the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 331 days |
| Price | $24.99 |
| Valuation | N/A trailing · N/A forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 1.52 |
The business, in plain words · what the numbers mean
| Revenue growth | 65.5% growing very fast |
| Profit margin | 18.9% healthy profit margins |
| Return on equity | 233.3% an exceptional return on shareholder capital |
| Debt to equity | 8.10 heavy leverage — higher risk if revenue softens |
| Current ratio | 5.24 comfortably covers its short-term bills |
| Beta | 1.52 much more volatile than the market |
| Employees | 985 |
The risks · The things to watch: it already moves more than the market on an average day; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & how to trade · wherever in the world you are
FTAIN trades on Nasdaq. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $24.89 | +0.3% | $0.52 | $1,024 | +2.4% |
| 2 months | $24.74 | +1.0% | $0.52 | $1,030 | +3.0% |
| 3 months | $24.76 | +0.9% | $0.52 | $1,029 | +2.9% |
| 6 months | $24.29 | +2.8% | $1.03 | $1,071 | +7.1% |
| 1 year | $23.25 | +7.4% | $2.06 | $1,163 | +16.3% |
| 2 years | $21.70 | +15.1% | $4.13 | $1,341 | +34.1% |
| 3 years | $17.78 | +40.4% | $6.19 | $1,753 | +75.3% |
| 5 years | $17.91 | +39.4% | $10.32 | $1,970 | +97.0% |
Historical returns from market close data. Past performance does not guarantee future results.